These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18473811)

  • 1. Targeted therapies in the treatment of renal cell carcinoma.
    Pezaro C; Davis ID
    Curr Med Chem; 2008; 15(12):1166-74. PubMed ID: 18473811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving role of novel targeted agents in renal cell carcinoma.
    Hutson TE; Figlin RA
    Oncology (Williston Park); 2007 Sep; 21(10):1175-80; discussion 1184, 1187, 1190. PubMed ID: 17926797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and angiogenic inhibitors in renal cell carcinoma.
    Sawhney R; Kabbinavar F
    Curr Urol Rep; 2008 Jan; 9(1):26-33. PubMed ID: 18366971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review.
    Badal SAM; Aiken WD; Chin SN
    Curr Drug Targets; 2017; 18(10):1204-1213. PubMed ID: 27138755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present strategies in the treatment of metastatic renal cell carcinoma: an update on molecular targeting agents.
    Bellmunt J; Montagut C; Albiol S; Carles J; Maroto P; Orsola A
    BJU Int; 2007 Feb; 99(2):274-80. PubMed ID: 17092282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic therapy in renal cell cancer.
    Srinivasan R; Armstrong AJ; Dahut W; George DJ
    BJU Int; 2007 May; 99(5 Pt B):1296-300. PubMed ID: 17441927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies for kidney cancer in urologic practice.
    Haas NB; Uzzo RG
    Urol Oncol; 2007; 25(5):420-32. PubMed ID: 17826664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of angiogenesis inhibitors on renal cell carcinoma].
    Bodrogi I
    Magy Onkol; 2007; 51(2):145-53. PubMed ID: 17660871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of angiogenesis inhibitory combination therapies for treatment of renal cell carcinoma].
    Bartsch G; Eggert K; Soker S; Fiedler W; Laack E; Volkmer BG; Gschwend J; Bokemeyer C; Hautmann R; Schuch G
    Urologe A; 2007 Sep; 46(9):1289-90. PubMed ID: 17624513
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney cancer: current and novel treatment options.
    Jonasch E
    J Natl Compr Canc Netw; 2015 May; 13(5 Suppl):679-81. PubMed ID: 25995429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pazopanib for the treatment of renal cancer.
    Al-Marrawi MY; Rini B
    Expert Opin Pharmacother; 2011 May; 12(7):1171-89. PubMed ID: 21470066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy for non-clear cell histologies in renal cancer.
    Bitting RL; Madden J; Armstrong AJ
    Curr Clin Pharmacol; 2011 Aug; 6(3):169-80. PubMed ID: 21861801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
    Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of pazopanib in the treatment of renal cell carcinoma.
    Zivi A; Cerbone L; Recine F; Sternberg CN
    Expert Opin Drug Saf; 2012 Sep; 11(5):851-9. PubMed ID: 22861374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF inhibitors in renal cell carcinoma.
    Vachhani P; George S
    Clin Adv Hematol Oncol; 2016 Dec; 14(12):1016-1028. PubMed ID: 28212363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in targeted therapy for renal cell carcinoma.
    Clark PE
    Curr Opin Urol; 2007 Sep; 17(5):331-6. PubMed ID: 17762626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapies for renal cell carcinoma.
    Syed S; Tolcher AW
    Cancer Treat Res; 2003; 116():227-38. PubMed ID: 14650836
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach.
    Bukowski RM
    Expert Opin Pharmacother; 2010 Oct; 11(14):2351-62. PubMed ID: 20586712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms.
    Mulders P
    BJU Int; 2009 Dec; 104(11):1585-9. PubMed ID: 20053190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.